1. Truncated WT1 Protein Isoform Expression Is Increased in MCF-7 Cells with Long-Term Estrogen Depletion
   Saavedra-Alonso Santiago et al, 2021, International Journal of Breast Cancer CrossRef
2. Chemosensitivity of three patient-derived primary cultures of canine pericardial mesothelioma by single-agent and combination treatment
   Rina Nabeta et al, 2023, Frontiers in Veterinary Science CrossRef
3. Anti-apoptotic function of T-KTS+, T-KTS-, WT1+/+ and WT1+/- isoforms in breast cancer
   Potchanapond Graidist et al, 2010, Asian Biomedicine CrossRef
4. Immunotherapy against Gliomas
   Mathew Sebastian et al, 2022, Brain Tumors CrossRef
5. Wilms' Tumor 1 Gene Expression in Hepatocellular Carcinoma Promotes Cell Dedifferentiation and Resistance to Chemotherapy
   Maria J. Perugorria et al, 2009, Cancer Research CrossRef
6. Wilms' Tumor Protein 1 and Enzymatic Oxidation of 5-Methylcytosine in Brain Tumors: Potential Perspectives
   Ashley Ramsawhook et al, 2018, Frontiers in Cell and Developmental Biology CrossRef
7. G-quadruplex forming region within WT1 promoter is selectively targeted by daunorubicin and mitoxantrone: A possible mechanism for anti-leukemic effect of drugs
   Saeedeh Ghazaey Zidanloo et al, 2019, Journal of Biosciences CrossRef
8. Kolon Poliplerinde WT1 Ekspresyonunun İncelenmesi
   Ali ASLAN et al, 2018, Anadolu Kliniği Tıp Bilimleri Dergisi CrossRef
9. DNA Methylation Readers and Cancer: Mechanistic and Therapeutic Applications
   Niaz Mahmood et al, 2019, Frontiers in Oncology CrossRef
10. Evaluating Established Roles, Future Perspectives and Methodological Heterogeneity for Wilms’ Tumor 1 (WT1) Antigen Detection in Adult Renal Cell Carcinoma, Using a Novel N-Terminus Targeted Antibody (Clone WT49)
    Dorin Novacescu et al, 2022, Biomedicines CrossRef